Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510(k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation, and teamwork.

(RTTNews) - Monogram Biosciences Inc.(MGRM), Monday announced that the U.S. Food and Drug Administration or FDA has granted 510(k) clearance for its Monogram mBôs TKA System, a robotic-assisted ...

FDA Decision is Expected Within 90 Days of Initial Submission; However, the Process May be Paused if Additional Information is Requested AUSTIN, TX / ACCESSWIRE / August 8, 2024 / Monogram ...

Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510(k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation, and teamwork.

Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System ACCESS Newswire. March 17, 2025 4:20 AM.

Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System ACCESS Newswire. March 17, 2025 7:20 AM.

Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System ACCESS Newswire. March 17, 2025 4:20 AM.